120 related articles for article (PubMed ID: 38471483)
1. Effect of Renin-Angiotensin System Blockers in Acute Myocardial Infarction Patients with Acute Kidney Injury.
Kim KA; Lee JE; Choi IJ; Lee KY; Kim CJ; Park MW; Park CS; Kim HY; Yoo KD; Jeon DS; Jeong MH; Chang K
Cardiorenal Med; 2024; 14(1):178-190. PubMed ID: 38471483
[TBL] [Abstract][Full Text] [Related]
2. Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR).
Kim KH; Choi BG; Rha SW; Choi CU; Jeong MH;
BMC Cardiovasc Disord; 2021 May; 21(1):251. PubMed ID: 34020593
[TBL] [Abstract][Full Text] [Related]
3. Renin-Angiotensin System Blockade after Acute Kidney Injury (AKI) and Risk of Recurrent AKI.
Hsu CY; Liu KD; Yang J; Glidden DV; Tan TC; Pravoverov L; Zheng S; Go AS
Clin J Am Soc Nephrol; 2020 Jan; 15(1):26-34. PubMed ID: 31843974
[TBL] [Abstract][Full Text] [Related]
4. The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction.
Wetmore JB; Tang F; Sharma A; Jones PG; Spertus JA
Am Heart J; 2015 Oct; 170(4):735-43. PubMed ID: 26386797
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
Evans M; Carrero JJ; Szummer K; Åkerblom A; Edfors R; Spaak J; Jacobson SH; Andell P; Lindhagen L; Jernberg T
J Am Coll Cardiol; 2016 Apr; 67(14):1687-97. PubMed ID: 27056774
[TBL] [Abstract][Full Text] [Related]
7. Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury.
Brar S; Liu KD; Go AS; Hsu RK; Chinchilli VM; Coca SG; Garg AX; Himmelfarb J; Ikizler TA; Kaufman J; Kimmel PL; Parikh CR; Siew ED; Ware LB; Zeng H; Hsu CY; ;
Clin J Am Soc Nephrol; 2020 Dec; 16(1):26-36. PubMed ID: 33272913
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effects of renin-angiotensin system blockades on 2 year outcomes in coronary artery ectasia patients.
Wang Y; Wang Y; Yin D; Dou K; Wu Y; Song W
Curr Med Res Opin; 2017 Sep; 33(9):1677-1684. PubMed ID: 28598221
[TBL] [Abstract][Full Text] [Related]
9. [Effects of hemoglobin level on the risk of acute kidney injury in patients with acute myocardial infarction].
Sun L; Chi B; Mao L; Zou A; Wang Q; Jiang J; Ji Y; Zhou X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1243-1247. PubMed ID: 36567576
[TBL] [Abstract][Full Text] [Related]
10. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
[TBL] [Abstract][Full Text] [Related]
11. The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
Her AY; Choi BG; Rha SW; Kim YH; Choi CU; Jeong MH
PLoS One; 2020; 15(11):e0242314. PubMed ID: 33253206
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
[TBL] [Abstract][Full Text] [Related]
13. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction.
Raposeiras-Roubín S; Abu-Assi E; Cespón-Fernández M; Ibáñez B; García-Ruiz JM; D'Ascenzo F; Simao Henriques JP; Saucedo J; Caneiro-Queija B; Cobas-Paz R; Muñoz-Pousa I; Wilton SB; González Juanatey JR; Kikkert WJ; Núñez-Gil I; Ariza-Solé A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Gaita F; Huczek Z; Nie SP; Yan Y; Fujii T; Correia L; Kawashiri MA; Kedev S; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Giordana F; Kowara M; Filipiak K; Wang X; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Íñiguez-Romo A
Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):114-122. PubMed ID: 31105064
[TBL] [Abstract][Full Text] [Related]
14. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.
Tsai TT; Patel UD; Chang TI; Kennedy KF; Masoudi FA; Matheny ME; Kosiborod M; Amin AP; Messenger JC; Rumsfeld JS; Spertus JA
JACC Cardiovasc Interv; 2014 Jan; 7(1):1-9. PubMed ID: 24456715
[TBL] [Abstract][Full Text] [Related]
15. Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.
Gayat E; Hollinger A; Cariou A; Deye N; Vieillard-Baron A; Jaber S; Chousterman BG; Lu Q; Laterre PF; Monnet X; Darmon M; Leone M; Guidet B; Sonneville R; Lefrant JY; Fournier MC; Resche-Rigon M; Mebazaa A; Legrand M;
Intensive Care Med; 2018 May; 44(5):598-605. PubMed ID: 29766216
[TBL] [Abstract][Full Text] [Related]
16. Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury.
Brar S; Ye F; James MT; Hemmelgarn B; Klarenbach S; Pannu N;
JAMA Intern Med; 2018 Dec; 178(12):1681-1690. PubMed ID: 30422153
[TBL] [Abstract][Full Text] [Related]
17. Effect of renin-angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in Japan.
Tsuchimoto A; Masutani K; Ueki K; Nakagawa K; Matsukuma Y; Tanaka S; Unagami K; Kakuta Y; Okumi M; Noguchi H; Kaku K; Okabe Y; Nakano T; Kitazono T; Nakamura M; Ishida H; Tanabe K;
Clin Exp Nephrol; 2020 Apr; 24(4):369-378. PubMed ID: 31875930
[TBL] [Abstract][Full Text] [Related]
18.
Pei Y; Miu M; Mao X; Chen W; Zhu J
Int J Clin Pract; 2023; 2023():8244545. PubMed ID: 38187354
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Am J Cardiovasc Drugs; 2019 Aug; 19(4):403-414. PubMed ID: 30788675
[TBL] [Abstract][Full Text] [Related]
20. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
